Helen Neville-Webbe

1.6k total citations
19 papers, 1.1k citations indexed

About

Helen Neville-Webbe is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Helen Neville-Webbe has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Helen Neville-Webbe's work include Bone health and treatments (14 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Bone Metabolism and Diseases (4 papers). Helen Neville-Webbe is often cited by papers focused on Bone health and treatments (14 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Bone Metabolism and Diseases (4 papers). Helen Neville-Webbe collaborates with scholars based in United Kingdom, Netherlands and Austria. Helen Neville-Webbe's co-authors include Robert E. Coleman, Ingunn Holen, Janet E. Brown, Catherine A. Evans, Caroline A. Evans, Amin Rostami‐Hodjegan, Colby L. Eaton, Neil A. Cross, Michael Gnant and Sabapathy P. Balasubramanian and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and European Journal of Cancer.

In The Last Decade

Helen Neville-Webbe

19 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Neville-Webbe United Kingdom 16 811 361 332 248 159 19 1.1k
Regina A. Swift United States 22 1.2k 1.5× 974 2.7× 438 1.3× 162 0.7× 185 1.2× 103 2.0k
E.D. Kreuser Germany 18 797 1.0× 202 0.6× 219 0.7× 187 0.8× 103 0.6× 48 1.2k
Theodore A. Vandenberg Canada 12 463 0.6× 206 0.6× 97 0.3× 110 0.4× 43 0.3× 26 774
Elena Verri Italy 17 711 0.9× 324 0.9× 133 0.4× 551 2.2× 32 0.2× 55 1.2k
Claudia Fleissner Germany 21 974 1.2× 851 2.4× 62 0.2× 83 0.3× 48 0.3× 33 1.6k
Julie M. Blair Australia 9 368 0.5× 260 0.7× 98 0.3× 118 0.5× 76 0.5× 12 768
Leonard Christopher Schmeel Germany 16 237 0.3× 130 0.4× 282 0.8× 120 0.5× 94 0.6× 67 816
M. Bonsignori Italy 10 509 0.6× 81 0.2× 88 0.3× 162 0.7× 129 0.8× 24 602
Nigel J. Parr United Kingdom 17 201 0.2× 399 1.1× 45 0.1× 180 0.7× 70 0.4× 42 917
Carolyn Chadwick United Kingdom 14 153 0.2× 199 0.6× 68 0.2× 199 0.8× 126 0.8× 36 713

Countries citing papers authored by Helen Neville-Webbe

Since Specialization
Citations

This map shows the geographic impact of Helen Neville-Webbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Neville-Webbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Neville-Webbe more than expected).

Fields of papers citing papers by Helen Neville-Webbe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Neville-Webbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Neville-Webbe. The network helps show where Helen Neville-Webbe may publish in the future.

Co-authorship network of co-authors of Helen Neville-Webbe

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Neville-Webbe. A scholar is included among the top collaborators of Helen Neville-Webbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Neville-Webbe. Helen Neville-Webbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Smyth, Elizabeth, Samuel Rowley, Fay Cafferty, et al.. (2019). Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma. JAMA Oncology. 5(8). 1181–1181. 18 indexed citations
2.
Neville-Webbe, Helen, Helen Wong, & Ernie Marshall. (2016). Patterns of acute oncology admissions: an exploratory analysis of over 7000 patient episodes. Postgraduate Medical Journal. 92(1093). 649–652. 1 indexed citations
3.
Marshall, Ernie, Monika K. Krzyzanowska, Bridget A. Robinson, et al.. (2016). Responding to Acute Care Needs of Patients With Cancer: Recent Trends Across Continents. The Oncologist. 21(3). 301–307. 30 indexed citations
4.
Marshall, Ernie, et al.. (2012). Innovation: When the big 'C' stands for creativity.. PubMed. 122(6307). 26–7. 1 indexed citations
5.
Neville-Webbe, Helen & Robert E. Coleman. (2010). Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease. European Journal of Cancer. 46(7). 1211–1222. 69 indexed citations
6.
Coleman, Robert E., Roger Burkinshaw, Matthew Winter, et al.. (2010). Zoledronic acid. Expert Opinion on Drug Safety. 10(1). 133–145. 27 indexed citations
7.
Neville-Webbe, Helen, Michael Gnant, & Robert E. Coleman. (2010). Potential Anticancer Properties of Bisphosphonates. Seminars in Oncology. 37. S53–S65. 56 indexed citations
8.
Buckle, Clive, Helen Neville-Webbe, Peter I. Croucher, & Michelle A. Lawson. (2010). Targeting RANK/RANKL in the Treatment of Solid Tumours and Myeloma. Current Pharmaceutical Design. 16(11). 1272–1283. 11 indexed citations
9.
Neville-Webbe, Helen, Robert E. Coleman, & Ingunn Holen. (2010). Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction. British Journal of Cancer. 102(6). 1010–1017. 42 indexed citations
10.
Hodgkinson, Elizabeth, Helen Neville-Webbe, & Robert E. Coleman. (2006). Magnesium Depletion in Patients Receiving Cisplatin-based Chemotherapy. Clinical Oncology. 18(9). 710–718. 46 indexed citations
11.
Neville-Webbe, Helen, Caroline A. Evans, Robert E. Coleman, & Ingunn Holen. (2006). Mechanisms of the Synergistic Interaction between the Bisphosphonate Zoledronic Acid and the Chemotherapy Agent Paclitaxel in Breast Cancer Cells in vitro. Tumor Biology. 27(2). 92–103. 77 indexed citations
12.
Holen, Ingunn, Simon S. Cross, Helen Neville-Webbe, et al.. (2005). Osteoprotegerin (OPG) Expression by Breast Cancer Cells in vitro and Breast Tumours in vivo – A Role in Tumour Cell Survival?. Breast Cancer Research and Treatment. 92(3). 207–215. 96 indexed citations
13.
Woodward, Julia K. L., Helen Neville-Webbe, Robert E. Coleman, & Ingunn Holen. (2005). Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitro. Anti-Cancer Drugs. 16(8). 845–854. 36 indexed citations
14.
Cross, Simon S., Zhiyong Yang, Nicola J. Brown, et al.. (2005). Osteoprotegerin (OPG)—a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis?. International Journal of Cancer. 118(8). 1901–1908. 93 indexed citations
15.
Brown, Janet E., Helen Neville-Webbe, & Robert E. Coleman. (2004). The role of bisphosphonates in breast and prostate cancers.. Endocrine Related Cancer. 11(2). 207–224. 96 indexed citations
16.
Neville-Webbe, Helen, Amin Rostami‐Hodjegan, Catherine A. Evans, Robert E. Coleman, & Ingunn Holen. (2004). Sequence‐ and schedule‐dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells. International Journal of Cancer. 113(3). 364–371. 126 indexed citations
17.
Neville-Webbe, Helen, Neil A. Cross, Colby L. Eaton, et al.. (2004). Osteoprotegerin (OPG) Produced by Bone Marrow Stromal Cells Protects Breast Cancer Cells from TRAIL-Induced Apoptosis. Breast Cancer Research and Treatment. 86(3). 271–282. 107 indexed citations
18.
Neville-Webbe, Helen & Robert E. Coleman. (2003). The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia. Palliative Medicine. 17(6). 539–553. 23 indexed citations
19.
Neville-Webbe, Helen, Ingunn Holen, & Robert E. Coleman. (2002). The anti-tumour activity of bisphosphonates. Cancer Treatment Reviews. 28(6). 305–319. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Regina A. Swift Breakdown of academic impact, for papers by E.D. Kreuser Breakdown of academic impact, for papers by Theodore A. Vandenberg Breakdown of academic impact, for papers by Elena Verri Breakdown of academic impact, for papers by Claudia Fleissner Breakdown of academic impact, for papers by Julie M. Blair Breakdown of academic impact, for papers by Leonard Christopher Schmeel Breakdown of academic impact, for papers by M. Bonsignori Breakdown of academic impact, for papers by Nigel J. Parr Breakdown of academic impact, for papers by Carolyn Chadwick
Rankless by CCL
2026